Glucotrack (GCTK) Shares Outstanding (Weighted Average) (2010 - 2025)

Glucotrack has disclosed Shares Outstanding (Weighted Average) across 16 years of filings, most recently posting $11.0 for Q4 2025.

• Quarterly Shares Outstanding (Weighted Average) fell 99.8% year-over-year to $11.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.0 (down 99.8% YoY) and the FY2025 annual result came in at $11.0, down 100.0% from the prior year.
• Shares Outstanding (Weighted Average) held at $11.0 in Q4 2025, from $11.0 in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $15.4 billion in Q1 2021 and troughed at $11.0 in Q3 2025.
• A 5-year average of $779.4 million and a median of $7.4 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Weighted Average) surged 8395.86% — and 2022, when it sank 99.9%.
• Tracing GCTK's Shares Outstanding (Weighted Average) over 5 years: stood at $15.5 million in 2021, then increased by 0.15% to $15.5 million in 2022, then slumped by 98.66% to $207603.0 in 2023, then tumbled by 97.35% to $5503.0 in 2024, then sank by 99.8% to $11.0 in 2025.
• Business Quant data shows GCTK's Shares Outstanding (Weighted Average) at $11.0 in Q4 2025, $11.0 in Q3 2025, and $332931.0 in Q2 2025.